Navigation Links
Pfizer Launches Viagra For Lung Disease In UK

Viagra, commonly used for treatment of erectile dysfunction or impotence can now be used in treating pulmonary arterial hypertension (PAH), a lung disease//. Pfizer, a leading pharmaceutical company, is marketing the drug under the brand name, Revatio, in the UK.

The drug approved for use in last November by the European based drug regulatory authority, contains the same active ingredients as the pill, Viagra. The drug is already being sold in Germany since January 2006. The world’s biggest drug manufacturer launched Revatio in the US, last August.

Pulmonary arterial hypertension, as the name suggests is a disorder characterized by elevated blood pressure levels in the pulmonary artery that carries blood to the lungs. The blood vessel disorder is frequently seen in women between the age of 20 to 40 years. More than 100,000 people worldwide are believed to suffer from this disorder.

Following the launch of Revatio in Britain, Tracleer medicine, a leading product for the condition, manufactured by Switzerland based Actelion is facing a tough competition.


'"/>




Page: 1

Related medicine news :

1. Pfizer unveils anti-smoking drug
2. The Effectiveness Of The Breast Cancer Drug By Pfizer
3. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
4. Erectile Dysfunction Drug Viagra Launched In India By Pfizer
5. Pfizer’s Eraxis Approved By The FD
6. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
7. Pfizer Commences Its Advertising for Celebrex with All the Warnings
8. FDA Approves Pfizer’s Anti-smoking Dru
9. Pfizer vouches safety of long-term inhaled insulin.
10. NICE Setback Rules for Pfizers Inhaled Insulin
11. Patency On Two Drugs From Merck & Pfizer’s To Expire Soo
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pfizer Launches Viagra For Lung Disease

(Date:12/2/2008)... UCSF Medical Center ranks No. 1 nationwide for...eated using balloon angioplasty, according to the ... (Vocus) December 2, 2008 --...e speed with which heart attack patients are treat...ional Cardiovascular Data Registry (NCDR). Cardia...
(Date:12/2/2008)...ps establish special bonds between partners. Often...erships, and ultimately, the start of families. ,...oo much emotional weight on their relationship. As... self-worth solely based on the outcomes of their ...term as relationship-contingent self-esteem (RCSE)...
(Date:12/2/2008)...swire/ -- Breast-Specific Gamma Imaging (BSGI) has...hnique for the diagnosis of,invasive lobular carc.... BSGI,is a molecular breast imaging technique th...and discover very early stage cancers. When compar...nce imaging (MRI), BSGI has the,greatest sensitiv...
(Date:12/2/2008)...Newswire-USNewswire/ -- In an open letter to Presi...omes and Services for the Aging (AAHSA) President ...the Obama administration can make both short-term ...merica cares for its most vulnerable people. , ...Nation,s Work Force: Create Jobs in Aging Services...
Breaking Medicine News(10 mins):Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 2Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 3Health News:Too much commitment may be unhealthy for relationships, UH psychology professor says 2Health News:Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI for Invasive Lobular Carcinoma 2
...s of herbal dietary supplements have skyrocketed b... 10 years, but most people dont consider evidence... a University of Iowa study published in this mont...rds of people who use herbs dont do so in accordan...
...w study examines the use of tissue-engineered scaf...ted ability to heal naturally, to replace defectiv...d and seeded to the scaffold which is implanted in...rtilage tissue is grown along the structure. The s...
...kthrough research has offered a clue as to why ora... in persons not regarded as primary-risk candidate...ky sexual act that passes on the human papillomavi... oral cancer even if the person does not smoke, dr...
...w vaccine aimed at preventing cervical cancer is n...of the human papillomavirus (HPV) responsible for...nwide study of the vaccine will be published in th...urnal of Medicine. But for the next generation of...
Other Medicine News:Health News:Swallowing The Bitter Pill-Oral Sex Linked To Oral Cancer 2Health News:Study Shows Continued Success for New HPV Vaccine Against Virus 2
(Date:11/30/2008)...SNewswire/ -- Older adults who exercise regularly ...umber of small blood vessels in the brain, accordi...ng of the Radiological Society of North America (R...versity of North Carolina ( UNC) - Chapel Hill , ...s who exercise to brain scans of those who do not....
(Date:11/27/2008)...phoblastic leukemia relapse cases arise from a cel..., MEMPHIS, Tenn., Nov. 27 /PRNewswire-USNewswire...spital have identified distinctive genetic changes...blastic leukemia (ALL) that cause relapse. The fin...ALL relapse in children and, ultimately, in adults...
(Date:11/25/2008)... , Audio and Web Video Resources to accompan... Blog. Please see the bottom of this release for d... A Mayo Clinic study sho...re having a stroke -- and as a result -- delay see...findings appear in the current issue of Emergency ...
(Date:11/25/2008)...ewswire-FirstCall/ -- Poniard,Pharmaceuticals, In...focused on,innovative oncology therapies, announc...rnatives for its preclinical research programs in ... on the clinical development of picoplatin,its l...commercialization of,picoplatin in the treatment ...
Breaking Medicine Technology:Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program 10850 1Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program 10850 2Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program 10850 3Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program 10850 4Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio 2971 1Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio 2971 2Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio 2971 3The Beryl Companies Hires Nancy Lecroy as Vice President of Marketing Communications 10848 1Rosetta Genomics Establishes Medical Advisory Board 2970 1Rosetta Genomics Establishes Medical Advisory Board 2970 2Rosetta Genomics Establishes Medical Advisory Board 2970 3Rosetta Genomics Establishes Medical Advisory Board 2970 4Rosetta Genomics Establishes Medical Advisory Board 2970 5
...- Late Life Weight Loss and "Motivational Reserve"...une 10, 2007 /PRNewswire-USNewswire/ -- A new stud...sease and stroke,such as high blood pressure and ...disease, according to research reported today at t...rence on Prevention,of Dementia in Washington, DC....
... CHICAGO, IL, Jun 09, 2007 (MARKET WIRE via COMTEX...lly owned subsidiary of Endo,Pharmaceuticals Holdi...m a Phase III randomized, double-blind, placebo-co...ptan succinate) 2.5 mg,tablets as a six-day preven...menstrual migraine (MM). The data demonstrated,tha...
Other Medicine Technology:Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 2Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 3Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 4Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 5Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 6Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 7Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 2Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 3Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 4Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 5Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 7
The ALB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of albumin in serum
For the quantitative in vitro determination of Inorganic Phosphorous in serum.
The TBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of total bilirubin in serum and plasma
The LDH method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of lactate dehydrogenase activity in serum or plasma
Medicine Products: